Reuters logo
4 months ago
BRIEF-Alliqua Biomedical says co and Celgene entered into side letter agreement
March 15, 2017 / 7:29 PM / 4 months ago

BRIEF-Alliqua Biomedical says co and Celgene entered into side letter agreement

1 Min Read

March 15 (Reuters) - Alliqua Biomedical Inc

* On March 13, 2017, co and Celgene entered into a side letter agreement - sec filing

* co, chairman Jerome Zeldis entered into side letter agreement; Zeldis to conditionally waive MFN adjustment in securities purchase deal

* Celgene agreed to waive MFN adjustment in spa to extent MFN adjustment would cause Celgene to own in excess of 19.9% of co's common stock Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below